Deltex Medical Group plc
DTXMF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.8% | 196.8% | -66.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 69.3% | 66.8% | 9.9% | 66.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -40.7% | -37.9% | -34.3% | -14.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -126.1% | -51.3% | -200.6% | -50.8% |
| EPS Diluted | -0.001 | -0 | -0 | -0.001 |
| % Growth | -133.3% | 25% | 50% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |